Top

Cardiovascular Intervention and Therapeutics

Published in:

01-10-2017 | Case Report

Non-occlusive mesenteric ischemia accompanied by aortic regurgitation after transcatheter aortic valve implantation

Authors: Kentaro Meguro, Junro Ishizaki, Tomoyoshi Yanagisawa, Toshimi Koitabashi, Tadashi Kitamura, Junya Ako

Published in: Cardiovascular Intervention and Therapeutics | Issue 4/2017

Abstract

An 81-year-old male with severe symptomatic aortic stenosis with ventricular tachycardia was referred for treatment. Balloon aortic valvuloplasty was performed under cardiopulmonary resuscitation. Though transcatheter aortic valve implantation (TAVI) was considered high risk for annulus rupture and aortic regurgitation due to annular calcification, TAVI was performed because of extremely high surgical risk. Moderate-to-severe aortic regurgitation (AR) remained and progression of acidosis could not be managed with continuous hemodiafiltration. His autopsy revealed the development of non-occlusive mesenteric ischemia (NOMI) as the cause of progressive acidosis. AR and hemodynamic instability might contribute to the development and progression of NOMI after TAVI.

Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.CrossRefPubMed

Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefPubMed

Ussia GP, Mule M, Barbanti M, Cammalleri V, Scarabelli M, Imme S, et al. Quality of life assessment after percutaneous aortic valve implantation. Eur Heart J. 2009;30(14):1790–6.CrossRefPubMed

Tamburino C, Capodanno D, Ramondo A, Petronio AS, Ettori F, Santoro G, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123(3):299–308.CrossRefPubMed

Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116(7):755–63.CrossRefPubMed

Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585–95.CrossRefPubMed

Barbanti M, Yang TH, Rodes Cabau J, Tamburino C, Wood DA, Jilaihawi H, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128(3):244–53.CrossRefPubMed

Meguro K, Lellouche N, Yamamoto M, Fougeres E, Monin JL, Lim P, et al. Prognostic value of QRS duration after transcatheter aortic valve implantation for aortic stenosis using the CoreValve. Am J Cardiol. 2013;111(12):1778–83.CrossRefPubMed

Nagasawa A, Shirai S, Hanyu M, Arai Y, Kamioka N, Hayashi M. Descending aortic dissection injured by tip of the sheath during transcatheter aortic valve implantation. Cardiovasc Interv Ther. 2016;31(2):122–7.CrossRefPubMed

10.

Boley SJ, Brandt LJ, Sammartano RJ. History of mesenteric ischemia. The evolution of a diagnosis and management. Surg Clin N Am. 1997;77(2):275–88.CrossRefPubMed

11.

Mitsuyoshi A, Obama K, Shinkura N, Ito T, Zaima M. Survival in nonocclusive mesenteric ischemia: early diagnosis by multidetector row computed tomography and early treatment with continuous intravenous high-dose prostaglandin E(1). Ann Surg. 2007;246(2):229–35.CrossRefPubMedPubMedCentral

12.

Schoots IG, Koffeman GI, Legemate DA, Levi M, van Gulik TM. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. 2004;91(1):17–27.CrossRefPubMed

13.

Groesdonk HV, Klingele M, Schlempp S, Bomberg H, Schmied W, Minko P, et al. Risk factors for nonocclusive mesenteric ischemia after elective cardiac surgery. J Thorac Cardiovasc Surg. 2013;145(6):1603–10.CrossRefPubMed

14.

Quiroga B, Verde E, Abad S, Vega A, Goicoechea M, Reque J, et al. Detection of patients at high risk for non-occlusive mesenteric ischemia in hemodialysis. J Surg Res. 2013;180(1):51–5.CrossRefPubMed

15.

Sastry P, Hardman G, Page A, Parker R, Goddard M, Large S, et al. Mesenteric ischaemia following cardiac surgery: the influence of intraoperative perfusion parameters. Interact Cardiovasc Thorac Surg. 1992;19(3):419–24.CrossRef

16.

Klotz S, Vestring T, Rotker J, Schmidt C, Scheld HH, Schmid C. Diagnosis and treatment of nonocclusive mesenteric ischemia after open heart surgery. Ann Thorac Surg. 2001;72(5):1583–6.CrossRefPubMed

17.

Trompeter M, Brazda T, Remy CT, Vestring T, Reimer P. Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol. 2002;12(5):1179–87.CrossRefPubMed

18.

Sinning JM, Hammerstingl C, Vasa-Nicotera M, Adenauer V, Lema Cachiguango SJ, Scheer AC, et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol. 2012;59(13):1134–41.CrossRefPubMed

19.

Watanabe Y, Lefevre T, Arai T, Hayashida K, Bouvier E, Hovasse T, et al. Can we predict postprocedural paravalvular leak after Edwards SAPIEN transcatheter aortic valve implantation? Catheter Cardiovasc Interv. 2015;86(1):144–51.CrossRefPubMed

20.

Cockburn J, Charlton T, Gomes A, Trivedi U, Hildick-Smith D. Transcatheter aortic valve implantation and simultaneous closure of associated paravalvular leak. Cardiovasc Interv Ther. 2015;31(1):56–60.CrossRefPubMed

21.

Webb J, Gerosa G, Lefevre T, Leipsic J, Spence M, Thomas M, et al. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol. 2014;64(21):2235–43.CrossRefPubMed

Title: Non-occlusive mesenteric ischemia accompanied by aortic regurgitation after transcatheter aortic valve implantation
Authors: Kentaro Meguro
Junro Ishizaki
Tomoyoshi Yanagisawa
Toshimi Koitabashi
Tadashi Kitamura
Junya Ako
Publication date: 01-10-2017
Publisher: Springer Japan
Published in: Cardiovascular Intervention and Therapeutics / Issue 4/2017
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI: https://doi.org/10.1007/s12928-016-0450-9

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Non-occlusive mesenteric ischemia accompanied by aortic regurgitation after transcatheter aortic valve implantation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2017

Impact of the Intracoronary Rendezvous technique on coronary angioplasty for chronic total occlusion

External and internal compressions to retrieve a kinked catheter in the right brachial artery

Transvenous Inoue balloon aortic valvuloplasty with intra-aortic balloon pump in treating cardiogenic shock due to critical calcific aortic stenosis

Hydrophilic polymer embolization: another differential diagnosis of iatrogenic leg embolization after transcatheter aortic valve replacement

Successful rotational atherectomy over RG3 guidewire after failure of various techniques to deliver RotaWire

Transcatheter closure of an atrial septal defect with high risk of erosion using a Figulla Flex II atrial septal defect occluder

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page